ZLWT-37
Product Specifications
Target
Others|||Apoptosis|||CDK
Related Pathways
Others|||Cell Cycle/Checkpoint|||Apoptosis
Bioactivity
ZLWT-37 is a potent, orally active inhibitor of CDKs, specifically targeting CDK9 (IC50: 0.002 ?M) and CDK2 (IC50: 0.054 ?M), and is capable of blocking the cell cycle of HCT116 cells in G2/M phase and inducing apoptosis.
Molecular Formula
C26H30ClN5O
Molecular Weight
464
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
135002-ML405 100 µL
UBE2K (Ubiquitin-conjugating Enzyme E2-25kD, Ubiquitin-protein Ligase, Ubiquitin Carrier Protein, E2 (25K), Huntingtin Interacting Protein 2, HIP-2, Ubiquitin-conjugating Enzyme E2 K, HIP2, LIG) (MaxLight 405) discontinued
Ask
View Details 
126345 50 µg
ENPP7 (NPP-7, UNQ3077/PRO9912, Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 7, Alkaline Sphingomyelin Phosphodiesterase, Intestinal Alkaline Sphingomyelinase, Alk-SMase, E-NPP 7, MGC50179)
Ask
View Details